Presenting author
Suresh Durgam
2 presentations
W38. Efficacy of lumateperone 42 mg for the treatment of major depressive disorder: Analysis of demographic and clinical subgroups in a phase 3 randomized placebo-controlled trial
T40. Adjunctive lumateperone 42 mg treatment in major depressive disorder: Efficacy across patient-reported depression symptoms